Invested In: 2026

Phitech is a TechBio company leading the global shift from DNA-only diagnostics to AI-powered multi-omics, setting a new gold standard for precision medicine in rare diseases and hereditary cancers. Their mission is to make diagnosis faster, more accessible, and more accurate for the 400+ million people with rare diseases and the millions affected by hereditary cancers.

https://www.phitech.bio/